AU6933794A - Pharmaceutical formulations - Google Patents

Pharmaceutical formulations

Info

Publication number
AU6933794A
AU6933794A AU69337/94A AU6933794A AU6933794A AU 6933794 A AU6933794 A AU 6933794A AU 69337/94 A AU69337/94 A AU 69337/94A AU 6933794 A AU6933794 A AU 6933794A AU 6933794 A AU6933794 A AU 6933794A
Authority
AU
Australia
Prior art keywords
pharmaceutical formulations
formulations
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU69337/94A
Inventor
Stewart Craig
Shilpa Patel
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vernalis R&D Ltd
Original Assignee
British Biotech Pharmaceuticals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by British Biotech Pharmaceuticals Ltd filed Critical British Biotech Pharmaceuticals Ltd
Publication of AU6933794A publication Critical patent/AU6933794A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/523—Beta-chemokines, e.g. RANTES, I-309/TCA-3, MIP-1alpha, MIP-1beta/ACT-2/LD78/SCIF, MCP-1/MCAF, MCP-2, MCP-3, LDCF-1, LDCF-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
AU69337/94A 1993-06-15 1994-06-15 Pharmaceutical formulations Abandoned AU6933794A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB939312344A GB9312344D0 (en) 1993-06-15 1993-06-15 Pharmaceutical formulations
GB9312344 1993-06-15
PCT/GB1994/001285 WO1994028917A1 (en) 1993-06-15 1994-06-15 Pharmaceutical formulations

Publications (1)

Publication Number Publication Date
AU6933794A true AU6933794A (en) 1995-01-03

Family

ID=10737205

Family Applications (1)

Application Number Title Priority Date Filing Date
AU69337/94A Abandoned AU6933794A (en) 1993-06-15 1994-06-15 Pharmaceutical formulations

Country Status (3)

Country Link
AU (1) AU6933794A (en)
GB (1) GB9312344D0 (en)
WO (1) WO1994028917A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8809419D0 (en) * 1988-04-21 1988-05-25 Pragnell I Stem cell inhibitors
CA2125985C (en) * 1991-12-23 2001-04-17 Stewart Craig Stem cell inhibiting proteins

Also Published As

Publication number Publication date
GB9312344D0 (en) 1993-07-28
WO1994028917A1 (en) 1994-12-22

Similar Documents

Publication Publication Date Title
AU7572196A (en) Pharmaceutical formulations
AU6995396A (en) Pharmaceutical formulation
AU1218892A (en) Pharmaceutical aerosol formulations
AU2087992A (en) Pharmaceutical combination formulation
AU6973396A (en) Pharmaceutical formulation
AU3716193A (en) Pharmaceutical compositions
AU7469494A (en) Anthelmintic formulations
AU5155096A (en) Pharmaceutical composition
AU2531295A (en) Pharmaceutical composition
AU7582696A (en) Pharmaceutical formulation
AU1189392A (en) Pharmaceutical agent
AU2392492A (en) Pharmaceutical composition
GB9311030D0 (en) Pharmaceutical formulations
GB9323399D0 (en) Pharmaceutical formulations
AU2537992A (en) Pharmaceutical compositions
AU1544195A (en) Pharmaceutical compositions
AU1427895A (en) Pharmaceutical compositions
AU6933794A (en) Pharmaceutical formulations
AU5049098A (en) Pharmaceutical formulation
AU6814496A (en) Pharmaceutical composition
AU3528593A (en) Pharmaceutical composition
AU8996291A (en) Pharmaceutical formulations
GB9304797D0 (en) Pharmaceutical formulations
GB9315119D0 (en) Pharmaceutical formulations
GB9304800D0 (en) Pharmaceutical formulations